Clinical Trials Logo

Laparoscopy clinical trials

View clinical trials related to Laparoscopy.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05773950 Enrolling by invitation - Clinical trials for Postoperative Nausea and Vomiting

Triple Therapy of Dexamethasone, Palonosetron, and Fosaprepitant as PONV Prevention

Start date: August 18, 2023
Phase: N/A
Study type: Interventional

As a preventive for postoperative nausea and vomiting in patients undergoing laparoscopic gynecological surgery, the investigators shall investigate the efficacy of the triple therapy of dexamethasone, palonosetron, and fosaprepitant comparing to dual therapy of dexamethasone and palonosetron.

NCT ID: NCT03837782 Enrolling by invitation - Laparoscopy Clinical Trials

Outcome of Resection for Colorectal Cancer

LRLCC
Start date: February 15, 2019
Phase: N/A
Study type: Interventional

There are limited data from retrospective studies regarding whether short-term and long-term outcomes after laparoscopic or robot-assisted radical colectomy (minimally invasive surgery) are equivalent to those after open abdominal radical colectomy (open surgery) among patients with early and medium-stage colorectal cancer. This trial is a multicenter,prospective, randomized trial evaluating short-term and survival outcomes concerning minimally invasive surgery and open surgery for colorectal cancer.

NCT ID: NCT03234543 Enrolling by invitation - Liver Diseases Clinical Trials

Remote Ischemic Conditioning in Abdominal Surgery

Start date: October 8, 2017
Phase: N/A
Study type: Interventional

This phase II randomized (1:1) controlled trial will examine the effects of remote ischemic conditioning (RIC) on the outcomes of major abdominal surgery. One hundred subjects will be enrolled at a single institution - University Hospital - Newark. The study population are patients undergoing major abdominal surgery (anticipated to be >/= 2 hrs long with a hospital stay >/= 2 days). Subjects in the treatment group will receive lower limb ischemic conditioning at 3 different time points: before surgery, POD 1 and POD 2. The primary outcome is the 30-day comprehensive complications index (CCI). Key secondary outcomes are changes in systemic inflammatory markers in peripheral blood and 30-day mortality.